Cargando…
Adipose stem cells isolated from diabetic mice improve cutaneous wound healing in streptozotocin-induced diabetic mice
BACKGROUND: Adipose-derived mesenchymal stem cells (ASCs) therapy is emerging as a novel therapeutic option for the treatment of a variety of diseases including diabetes and diabetic wound healing. Multiple studies indicate that ASCs could promote wound healing and reverse diabetes. However, whether...
Autores principales: | An, Ran, Zhang, Yong, Qiao, Yu, Song, Lili, Wang, Hongjun, Dong, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079496/ https://www.ncbi.nlm.nih.gov/pubmed/32183899 http://dx.doi.org/10.1186/s13287-020-01621-x |
Ejemplares similares
-
Adipose stem cells from type 2 diabetic mice exhibit therapeutic potential in wound healing
por: Sun, Yongfa, et al.
Publicado: (2020) -
Correction: Adipose stem cells from type 2 diabetic mice exhibit therapeutic potential in wound healing
por: Sun, Yongfa, et al.
Publicado: (2022) -
Comparison of EGF with VEGF Non-Viral Gene Therapy for Cutaneous Wound Healing of Streptozotocin Diabetic Mice
por: Ko, Junghae, et al.
Publicado: (2011) -
Nanofiber-expanded human CD34(+) cells heal cutaneous wounds in streptozotocin-induced diabetic mice
por: Kanji, Suman, et al.
Publicado: (2019) -
Antioxidant Sol-Gel Improves Cutaneous Wound Healing in Streptozotocin-Induced Diabetic Rats
por: Lee, Yen-Hsien, et al.
Publicado: (2012)